Aktie A3CUB9 ACCM SCIE
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen ACCM SCIE OTC Markets

Aktien

A3CUB9

US00442Y1010

ACMSY

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
AccuStem Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
AccuStem Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
AccuStem Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
AccuStem Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
AccuStem Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
AccuStem Sciences, Inc. and EmeritusDX Announce Joint Product Development Agreement and Strategic Partnership
Accustem Sciences, Inc. and Emeritusdx Announce Joint Product Development Agreement and Strategic Partnership
AccuStem Sciences, Inc. Extends and Broadens Partnership with Instituto Europeo di Oncologia (IEO) Enabling its Strategic Approach to Address Unanswered Clinical Questions in Early Stage Breast Cancer
ACCUSTEM SCIENCES INC. : Change in Directors or Principal Officers (form 8-K)
Accustem Sciences Inc. Announces Resignation of Jeff Fensterer as Chief Operating Officer, Effective as of June 16, 2023
AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals
AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals
AccuStem Announce Strategic Clinical and Operational Partnership
Accustem Sciences Inc. Announces Strategic Clinical and Operational Partnership
ACCUSTEM SCIENCES INC. : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AccuStem Sciences Announces Extension of its US Patent Application for SPARE Test for Patients with Breast Cancer
ACCUSTEM SCIENCES INC. : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
ACCUSTEM SCIENCES INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3C9E5 Aktie
  4. A3CUB9 Aktie
  5. Nachrichten ACCM SCIE
  6. Andere Sprachen